12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25-50 mg/day) versus escitalopram (10-20 mg/day) in out-patients with severe generalized anxiety disorder

Agomelatine and escitalopram are efficacious in treating GAD patients with severe symptoms.